News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Kiaema R. Reid, Porzio Pharmaceuitcal Services LLC

Advertisement

Articles by Kiaema R. Reid, Porzio Pharmaceuitcal Services LLC

The end or just the beginning? Exploring federal preemption of state marketing and distribution laws

BySarina D. Rivera, Esq., Jennifer A. Sanfilippo, Esq., Porzio, Bromberg & Newman PC,Kiaema R. Reid, Porzio Pharmaceuitcal Services LLC
February 22nd 2009

Multiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation

Advertisement

Latest Updated Articles

  • The end or just the beginning? Exploring federal preemption of state marketing and distribution laws
    The end or just the beginning? Exploring federal preemption of state marketing and distribution laws

    Published: February 22nd 2009 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Why Continuous Vendor Oversight Is Key to Healthcare Data Security

2

Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch

3

One Connection, Endless Impact: Improving Patient Medication Access

4

Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands

5

Reducing HIPAA Breaches

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us